Literature DB >> 8940747

Adenosine physiology and pharmacology: how about A2 receptors?

J L Daval1, F Nicolas, J F Doriat.   

Abstract

Adenosine participates in the physiology of central and peripheral tissues through several subtypes of G-protein-coupled receptors. Positively linked to adenylate cyclase, A2 receptors have been subdivided into A2a and A2b sites on the basis of their molecular, biochemical and pharmacological properties. They exhibit selective distribution, and are implicated in the modulation of psychomotor activity, circulation, respiration, and metabolism. Recent data support the evidence that adenosine A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of various disorders, including psychiatric diseases, hypoxia/ischemia, inflammation or erythrocytosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940747     DOI: 10.1016/s0163-7258(96)00094-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  4 in total

Review 1.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

2.  Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration.

Authors:  L Giraldez; F Zanetti; E Girardi
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

3.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

4.  Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.

Authors:  Aftab Ahmad; Shama Ahmad; Louise Glover; Stacy M Miller; John M Shannon; Xiaoling Guo; Wilbur A Franklin; James P Bridges; Jerome B Schaack; Sean P Colgan; Carl W White
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-17       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.